Almac Co. Ltd. (354320) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Almac Co. Ltd. (354320:KRX), powered by AI.

Current Price
₩53,700
P/E Ratio
-261.7
Market Cap
343.2B
Sector
Common Stock
What is the Almac Co. Ltd. stock price forecast?

Almac Co. Ltd. is currently trading at ₩53,700. View real-time AI analysis on Alpha Lenz.

What is Almac Co. Ltd. insider trading activity?

View the latest insider trading data for Almac Co. Ltd. on Alpha Lenz.

What is Almac Co. Ltd.'s P/E ratio?

Almac Co. Ltd.'s P/E ratio is -261.7.

Almac Co. Ltd.

KRX · 354320
₩53,700-3,700(-6.45%)Market closedKRX regular session 09:00–15:30 KST
Ask about Almac Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Almac Co. Ltd. trades at a P/E of -261.7 (undervalued) with modest ROE of -0.9%.

Ask for details

Company Overview

Almac Co. Ltd. is a prominent entity in the healthcare and pharmaceutical industry, primarily engaged in the provision of advanced drug development services. The company is dedicated to innovating and streamlining the complex processes involved in bringing therapeutic solutions from conceptual stages to market availability. With core competencies in research, development, and manufacturing, Almac Co. Ltd. significantly impacts both the biotechnology and pharmaceutical sectors. This company is renowned for its comprehensive service portfolio, which includes clinical trial management, bioscience research, global drug supply management, and specialized analytics. Almac Co. Ltd. operates a worldwide network, ensuring seamless integration and service delivery across various continents, thereby facilitating global healthcare advancement. Based in Craigavon, Northern Ireland, its extensive collaboration with researchers, scientists, and pharmaceutical companies highlights its pivotal role in expediting drug development cycles while maintaining stringent compliance with regulatory standards in multiple jurisdictions. As a result, Almac Co. Ltd. is crucial in reducing healthcare costs and improving medication accessibility on a global scale.

CEO신상호
SectorCommon Stock
IndustryCommon Stock
0

Company Statistics

FY 2025

Profile

₩343,217,159,700Market Cap
₩187,825,356,600Revenue
6.39MShares Out
0Employees

Margins

13.28%Gross
11.53%EBITDA
3.31%Operating
-1.04%Pre-Tax
-3.26%Net

Valuation

-261.68P/E
2.28P/B
1.83EV/Sales
22.44EV/EBITDA
-5647.17P/FCF

Growth (CAGR)

6.21%Rev 3Yr
20.31%Rev 5Yr
-17.99%Op Inc 3Yr
13.86%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-1.80%ROA
-0.90%ROE
1.31%ROIC

Financial Health

₩22,775,587,540Cash & Cash Equivalents
₩158,828,127,870Net Debt
112.69%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Almac Co. Ltd. (ticker: 354320) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $343.2B.

The current price is ₩53,700 with a P/E ratio of -261.68x and P/B of 2.28x.

ROE is -0.90% and operating margin is 3.31%. Annual revenue is $187.8B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Almac Co. Ltd. (354320) Stock Forecast 2026 ₩53,700 — Price, Financials & Analyst Targets | Alpha Lenz